ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 736

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Associated With Systemic Sclerosis In Japan: A Review Of The Literature

Natsumi Nagao1, Yuri Sadanaga1, Satoko Tashiro1, Rie Suematsu1, Syuichi Koarada1, Akihide Ohta2 and Yoshifumi Tada1, 1Rheumatology, Saga University, Saga, Japan, 2Nursing, Saga University, Saga, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: ANCA, systemic sclerosis and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Title: Vasculitis I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Cases of Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) during the course of systemic sclerosis (SSc) have recently been reported. Japanese cases of AAV associated with SSc were collected from the literature, and the characteristics of patients in Japan were analyzed.

Methods: A literature review was performed using MEDLINE and the database of the Japan Medical Abstracts Society. The following keywords were used: antineutrophil cytoplasmic antibody; vasculitis; and systemic sclerosis/scleroderma. Case reports, including proceedings and abstracts from Japan that were written in either English or Japanese, were identified. A total of 61 cases were reviewed, including 58 cases from 42 reports (6 in English and 36 in Japanese) and 3 cases from our hospital. The clinical features of SSc-associated AAV were compared with those reported by the AAV survey of the Ministry of Health, Labor and Welfare study group done between 2006 and 2008 in Japan.

Results: In SSc-associated AAV, the average age at onset was 57.0 years, which was 12.4 years earlier than for all AAV patients, and women developed the disease much more frequently than men. In SSc-associated AAV, the male:female ratio was 1:9, whereas the ratio was 1:1 in all AAV. In SSc, the proportions of the diffuse and the limited types were equal; anti-Scl-70 antibody was positive in 35 cases, and anti-centromere antibody was positive in 6 cases. The mean duration between diagnosis of SSc and AAV was 10.3 years (range, 1–41 years). In AAV, alveolar hemorrhage developed in 24%, and rapid progressive glomerulonephritis developed in 81%; both were more frequent than in all AAV as reported by the survey (11% and 63%, respectively). On the other hand, neurological manifestations were less frequent in SSc-associated AAV (24% versus 45%). No cases were positive for anti-PR3 antibody. Twelve cases died, and the most frequent cause of death was infection (7 cases).

Conclusion: SSc-associated AAV in Japan has several characteristics, including younger onset, female predominance, frequent pulmonary and renal manifestations, and long duration from SSc to AAV. It should be noted that this association is not extremely rare, and increased awareness may lead to earlier diagnosis and better prognoses.


Disclosure:

N. Nagao,
None;

Y. Sadanaga,
None;

S. Tashiro,
None;

R. Suematsu,
None;

S. Koarada,
None;

A. Ohta,
None;

Y. Tada,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/antineutrophil-cytoplasmic-antibody-associated-vasculitis-associated-with-systemic-sclerosis-in-japan-a-review-of-the-literature/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology